The T37A substitution increases both H5N6 M1 protein stability and H5N6 viral replication in mammals. by Chenxi Wang (284364)

Subjects:

Stimulation of Caco-2 cells with IFN-γ decreases claudin-4 expression. by Manigandan Lejeune (458492)

Fig 5 - by Torsten Schober (20485754)

V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Incidence and fitting values of Hepatitis predicted by three neural network models. by Zhaohui Xia (9406284)

Subjects:

RNN models. by Zhaohui Xia (9406284)

Subjects:

Prediction performance of the three neural network models. by Zhaohui Xia (9406284)

Subjects:

Impact of SARS‐CoV‐2 infection on T, B and NK cell numbers in patients compared with the control group (**** <i>P< 0</i>.<i>0001</i>). by Sam Alahyari (12645313)

Cytokine co-expression of SARS-CoV-2 specific T cells differs between PASC and RC. by Katherine M. Littlefield (12647420)

Luciferase expression in mice after intravenous injection rH17d’-Ad5 vectors as revealed by live BLI. by Christopher M. Gentile (6640331)

JHMV N1347A has decreased replication in the olfactory bulbs of mice. by Catherine M. Kerr (21492574)

rVλ6Wil fibrils cause oxidative stress in cardiomyocytes without a decrease in cellular ATP. by Helen P. McWilliams-Koeppen (116503)

“…<p>(A) After a 2 h incubation with rVλ6Wil fibrils or monomer, cellular ATP levels, as detected by luminescence (black bars), were not significantly reduced relative to the PBS-treated control. …”

Declining trend in the initial SARS-CoV-2 VL in hospitalized patients coinciding with a decrease in mortality rates. by Said El Zein (11442413)

Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial by David R. Clemmons (765381)

“…Total cholesterol (-0.3±0.6 mmol/L) and non-HDL cholesterol (-0.3±0.5 mmol/L) significantly decreased from baseline to Week 12 in the tesamorelin 2 mg group (p<0.05 vs. placebo). …”

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

Fig 7 - by Jan Maleček (17396660)

Subjects:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Overview of the study protocol. by Jan Maleček (17396660)

Subjects:

Mean countermovement jump height without (CON, white) and with ammonia inhalants (AI, black). by Jan Maleček (17396660)

Subjects: